Scientists at the University of Oxford, led by Professor Ahmed Ahmed, are designing OvarianVax, a vaccine which teaches the immune system to recognise and attack the earliest stages of ovarian cancer. The team will receive up to £600,000 for the study over the next three years to support lab research into the vaccine.
In this study, the CRUK-funded researchers will establish the targets for the vaccine. They will find out which proteins on the surface of early-stage ovarian cancer cells are most strongly recognised by the immune system and how effectively the vaccine kills mini-models of ovarian cancer called organoids.
If this research is successful, work will then begin on clinical trials of the vaccine. The hope is that in the future, women could be offered this vaccine to prevent ovarian cancer in the first place.
Read the full story on the MRC Weatherall Institute of Molecular Medicine (MRC WIMM) website.
more recommended stories
Rheumatoid Arthritis Linked to SPP1hi Macrophages GrowthKey Summary Researchers at Hospital for.
Resistance Training Reduces Type 2 Diabetes Risk in AdultsKey Takeaways Consistent resistance training was.
Cardiac Aging Research Identifies PRDM16 Heart RegulatorKey Takeaways Researchers created a single-nucleus.
Digital Heart Twins Show Promise for AF Ablation PrecisionKey Summary Researchers developed patient-specific digital.
Alzheimer’s Disease Study Questions Glucosamine SafetyKey Summary New research published in.
WHO: Andes Hantavirus Not a COVID-19-Level ThreatKey Summary Andes hantavirus has drawn.
Genetic Screening Project Launches for Brazilian ParentsKey Summary Brazil is launching the.
CAR T-Cell Therapy Offers Hope for Highly Sensitized PatientsKey Summary Researchers at the University.
Gut Keystone Bacteria: How Diet Shapes Microbiome HealthKey Takeaways Researchers are identifying “gut.
Chronic Liver Disease in Europe Raises Public Health AlarmKey Summary A new report in.
Leave a Comment